Skip to content
  • Start
  • News
  • Video
  • Podcast
  • Event
  • Premium
    • Premium Content
    • VC Database
    • Company Database
    • Soft Funding & Grants
    • Job Database
  • About BioStock
Log in Subscribe
Home / IRLAB Therapeutics

IRLAB Therapeutics

IRLAB receives 4 million USD for IRL757 study

The news sweep

News roundup Wednesday June 4

The news sweep

News roundup Wednesday, May 28

IRLAB reports positive Phase 1 results with IRL757

Bioteknik

IRLAB Therapeutics | Global Forum 2025

CEO Kristina Torfgård presents IRLAB Therapeutics at BioStock...

Video
News roundup Monday, May 19

News roundup Monday, May 12

Alligator Bioscience

News roundup Monday, May 19

News roundup Wednesday, May 7

Curasight

News roundup Monday, May 19

News roundup Tuesday, May 6

Nanexa

News roundup Monday, May 19

News round-up Monday, April 28

Magle PharmaCept

News roundup Monday, May 19

News round-up Monday, April 7

Sartorius

News roundup Monday, May 19

News roundup Tuesday, April 1

Spermosis

IRLAB is recovering

New data gives IRLAB new hope

IRLAB Therapeutics has presented in-depth analyses of data...

BioStock

  • Start
  • News
  • Video
  • Podcast
  • Event
  • About BioStock
  • Privacy Policy
  • Terms and Conditions

Read BioStock's newsletter

Get industry news, company information and invitations to BioStock events directly in your inbox!

Val*
This field is used for validation purposes and should be left unchanged.
© 2025 Biostock